1. Home
  2. TZOO vs ABEO Comparison

TZOO vs ABEO Comparison

Compare TZOO & ABEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TZOO
  • ABEO
  • Stock Information
  • Founded
  • TZOO 1998
  • ABEO N/A
  • Country
  • TZOO United States
  • ABEO United States
  • Employees
  • TZOO N/A
  • ABEO N/A
  • Industry
  • TZOO Advertising
  • ABEO Biotechnology: Pharmaceutical Preparations
  • Sector
  • TZOO Consumer Discretionary
  • ABEO Health Care
  • Exchange
  • TZOO Nasdaq
  • ABEO Nasdaq
  • Market Cap
  • TZOO 249.4M
  • ABEO 243.9M
  • IPO Year
  • TZOO 2002
  • ABEO 1980
  • Fundamental
  • Price
  • TZOO $20.98
  • ABEO $5.22
  • Analyst Decision
  • TZOO Strong Buy
  • ABEO Strong Buy
  • Analyst Count
  • TZOO 3
  • ABEO 3
  • Target Price
  • TZOO $25.00
  • ABEO $18.00
  • AVG Volume (30 Days)
  • TZOO 139.6K
  • ABEO 251.9K
  • Earning Date
  • TZOO 02-26-2025
  • ABEO 11-14-2024
  • Dividend Yield
  • TZOO N/A
  • ABEO N/A
  • EPS Growth
  • TZOO 38.38
  • ABEO N/A
  • EPS
  • TZOO 1.06
  • ABEO N/A
  • Revenue
  • TZOO $84,373,000.00
  • ABEO N/A
  • Revenue This Year
  • TZOO $3.00
  • ABEO N/A
  • Revenue Next Year
  • TZOO $14.48
  • ABEO $18,714.71
  • P/E Ratio
  • TZOO $20.54
  • ABEO N/A
  • Revenue Growth
  • TZOO 2.97
  • ABEO 147.52
  • 52 Week Low
  • TZOO $7.12
  • ABEO $3.05
  • 52 Week High
  • TZOO $22.44
  • ABEO $9.01
  • Technical
  • Relative Strength Index (RSI)
  • TZOO 56.91
  • ABEO 35.01
  • Support Level
  • TZOO $18.63
  • ABEO $5.05
  • Resistance Level
  • TZOO $21.68
  • ABEO $5.66
  • Average True Range (ATR)
  • TZOO 1.09
  • ABEO 0.26
  • MACD
  • TZOO -0.03
  • ABEO -0.06
  • Stochastic Oscillator
  • TZOO 66.20
  • ABEO 16.04

About TZOO Travelzoo

Travelzoo acts as a publisher of travel and entertainment offers. It operates in four segments. Travelzoo North America segment consists of operations in Canada and the U.S.; Travelzoo Europe segment consists of operations in France, Germany, Spain, and the U.K.; and Jack's Flight Club segment consists of subscription revenue from premium members to access and receive flight deals from Jack's Flight Club via email or via Android or Apple mobile applications; New Initiatives consists of Travelzoo's licensing activities in Asia Pacific territories. It derives its revenue through advertising fees including listing fees paid by travel, entertainment, and local businesses to advertise their offers on the company's media properties. Most of the company's revenue is derived from North America.

About ABEO Abeona Therapeutics Inc.

Abeona Therapeutics Inc is a clinical-stage biopharmaceutical company. The firm is focused on developing gene therapies and plasma-based products for life-threatening rare genetic diseases. Its clinical programs consist of pz-cel, an autologous, engineered cell therapy currently in development for recessive dystrophic epidermolysis bullosa (RDEB). The Company's development portfolio also features adeno-associated virus (AAV)-based gene therapies designed to treat unmet, medically needed ophthalmic diseases using the novel AIM.

Share on Social Networks: